Protalix BioTherapeutics (PLX) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | 610.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 610.16% |
| Dec 31, 2025 | -104.66% |
| Sep 30, 2025 | -46.60% |
| Jun 30, 2025 | 148.29% |
| Mar 31, 2025 | 14.64% |
| Dec 31, 2024 | 228.39% |
| Sep 30, 2024 | 311.50% |
| Jun 30, 2024 | -111.88% |
| Mar 31, 2024 | -97.48% |
| Dec 31, 2023 | -174.91% |
| Sep 30, 2023 | 39.62% |
| Jun 30, 2023 | 469.68% |
| Mar 31, 2023 | -31.50% |
| Dec 31, 2022 | 231.37% |
| Sep 30, 2022 | -65.78% |
| Jun 30, 2022 | 39.73% |
| Mar 31, 2022 | 49.53% |
| Dec 31, 2021 | -300.99% |
| Sep 30, 2021 | 26.99% |
| Jun 30, 2021 | -309.20% |
| Mar 31, 2021 | -178.95% |
| Dec 31, 2020 | 29.05% |
| Sep 30, 2020 | -67.23% |
| Jun 30, 2020 | 61.64% |
| Mar 31, 2020 | 184.80% |
| Dec 31, 2019 | 159.91% |
| Sep 30, 2019 | 58.73% |
| Jun 30, 2019 | 13.42% |
| Mar 31, 2019 | -7.44% |
| Dec 31, 2018 | 61.68% |
| Sep 30, 2018 | 51.82% |
| Jun 30, 2018 | 37.58% |
| Mar 31, 2018 | 19.07% |
| Dec 31, 2017 | -9.89% |
| Sep 30, 2017 | -16.80% |
| Jun 30, 2017 | -8.80% |
| Mar 31, 2017 | 19.06% |
| Dec 31, 2016 | -13.25% |
| Sep 30, 2016 | -32.91% |
| Jun 30, 2016 | -77.85% |
| Mar 31, 2016 | -46.06% |
| Mar 31, 2015 | 16.76% |
| Mar 31, 2014 | -46.04% |
| Dec 31, 2013 | -68.14% |
| Sep 30, 2013 | -1.53% |
| Jun 30, 2013 | -171.66% |
| Mar 31, 2013 | 26.97% |
| Dec 31, 2012 | -14.78% |
| Sep 30, 2012 | 36.58% |
| Jun 30, 2012 | 169.37% |
| Mar 31, 2012 | -20.39% |
| Dec 31, 2011 | -0.11% |
| Sep 30, 2011 | -207.83% |
| Jun 30, 2011 | -36.63% |